![\"15844543_s\"](\"https:\/\/cellsforlife.com\/wp-content\/uploads\/2013\/10\/15844543_s-297x300.jpg\")
<\/p>\nThe year of 2013 marks the 25th\u00a0anniversary of the first cord blood transplant. The transplant was performed in Paris on October 6, 1988. Since that time, over 600,000 cord blood units have been collected and stored in more than 100 public cord blood banks worldwide.<\/p>\n
The field of umbilical cord blood transplants (UCBT) has matured considerably over the last 25 years. Over 30,000 UCBTs have now been performed. Today, transplant physicians around the world use cord blood stem cells routinely to treat a wide-range of diseases, including: leukaemia, lymphoma, sickle cell anaemia, thallasaemia, immune system disorders, inborn metabolic errors, and following chemotherapy for cancer.<\/p>\n
Many positive changes have occurred in the field of cord blood stem cells over the last five to ten years.\u00a0The use of cord blood stem cells has amplified due to the following:<\/p>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Increased number of available cord blood units<\/p>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Increased experience in cord blood use<\/p>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Education of physicians in cord blood use<\/p>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Increased number of published studies showing positive clinical results<\/p>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Increased opportunities for sharing experiences, data and procedures through international conferences, publications and professional organizations<\/p>\n
There are many\u00a0anecdotal reports\u00a0circulating about the success in treating diseases with stem cells. It is important to realize that it may take a long time before many of these treatments can be used clinically.<\/p>\n
Clinical trials are currently underway for:<\/strong><\/p>\n